No 'Bad Faith' To Justify Fee Award In Docs Suit, Biogen Says
Biogen has told the Delaware Chancery Court it should reject a fee bid by firms representing an investor who claimed the company used "glaringly egregious" tactics aimed at driving up the...To view the full article, register now.
Already a subscriber? Click here to view full article